Cargando…

SBLC: a hybrid model for disease named entity recognition based on semantic bidirectional LSTMs and conditional random fields

BACKGROUND: Disease named entity recognition (NER) is a fundamental step in information processing of medical texts. However, disease NER involves complex issues such as descriptive modifiers in actual practice. The accurate identification of disease NER is a still an open and essential research pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Kai, Zhou, Zhanfan, Gong, Tao, Hao, Tianyong, Liu, Wenyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284263/
https://www.ncbi.nlm.nih.gov/pubmed/30526592
http://dx.doi.org/10.1186/s12911-018-0690-y
Descripción
Sumario:BACKGROUND: Disease named entity recognition (NER) is a fundamental step in information processing of medical texts. However, disease NER involves complex issues such as descriptive modifiers in actual practice. The accurate identification of disease NER is a still an open and essential research problem in medical information extraction and text mining tasks. METHODS: A hybrid model named Semantics Bidirectional LSTM and CRF (SBLC) for disease named entity recognition task is proposed. The model leverages word embeddings, Bidirectional Long Short Term Memory networks and Conditional Random Fields. A publically available NCBI disease dataset is applied to evaluate the model through comparing with nine state-of-the-art baseline methods including cTAKES, MetaMap, DNorm, C-Bi-LSTM-CRF, TaggerOne and DNER. RESULTS: The results show that the SBLC model achieves an F1 score of 0.862 and outperforms the other methods. In addition, the model does not rely on external domain dictionaries, thus it can be more conveniently applied in many aspects of medical text processing. CONCLUSIONS: According to performance comparison, the proposed SBLC model achieved the best performance, demonstrating its effectiveness in disease named entity recognition.